|
|
||||||||
1 INSERM U332
and2 INSERM U363, Institut Cochin de Génétique Moléculaire, Université Paris V-René Descartes, 22 rue Méchain, 75014 Paris, France
Although the human immunodeficiency virus type 1 (HIV-1) nef gene still has no precisely defined function, in vivo studies have demonstrated that Nef is an important pathogenic determinant of HIV. In order to identify cellular proteins capable of binding to Nef, the HIV-1LAI nef gene product was expressed in the bacterial vector pGEX-2T as a glutathione S-transferase (GST)-Nef fusion protein. Deletion mutants corresponding to 86 and 35 N-terminal residues of the Nef protein were prepared. The GST-Nef constructs were used to identify cellular kinases capable of interacting with Nef. After incubation with a Jurkat cell lysate, the GST-Nef constructs immobilized on glutathione-agarose beads bound to cellular kinase(s) and were phosphorylated at three sites in vitro: one on threonine at position 15, one on serine between residues 1 and 35, and one on threonine between residues 36 and 86. The Nef-phosphorylating activity was inhibited by protein kinase C (PKC)-selective inhibitors. Cell fractionation showed that this Nef-binding kinase was mainly in the membrane-associated fraction. These results suggest that kinase(s) of the PKC family are specifically bound to and phosphorylate Nef in vitro. The interaction of Nef with cellular kinases and its phosphorylation may be important in mediating the effects of Nef in HIV-1 pathogenesis.
* Author for correspondence. Fax +33 1 40 51 77 49. e-mail Russo@citi2.fr
Received 29 November 1994;
accepted 7 February 1995.
This article has been cited by other articles:
![]() |
P. Vincent, E. Priceputu, D. Kay, K. Saksela, P. Jolicoeur, and Z. Hanna Activation of p21-activated Kinase 2 and Its Association with Nef Are Conserved in Murine Cells but Are Not Sufficient to Induce an AIDS-like Disease in CD4C/HIV Transgenic Mice J. Biol. Chem., March 17, 2006; 281(11): 6940 - 6954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Megy, G. Bertho, J. Gharbi-Benarous, N. Evrard-Todeschi, G. Coadou, E. Segeral, C. Iehle, E. Quemeneur, R. Benarous, and J.-P. Girault STD and TRNOESY NMR Studies on the Conformation of the Oncogenic Protein {beta}-Catenin Containing the Phosphorylated Motif DpSGXXpS Bound to the {beta}-TrCP Protein J. Biol. Chem., August 12, 2005; 280(32): 29107 - 29116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Esfandiarei, H. Luo, B. Yanagawa, A. Suarez, D. Dabiri, J. Zhang, and B. M. McManus Protein Kinase B/Akt Regulates Coxsackievirus B3 Replication through a Mechanism Which Is Not Caspase Dependent J. Virol., April 15, 2004; 78(8): 4289 - 4298. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ali, S. Pillai, H. Ng, R. Lubong, D. D. Richman, B. D. Jamieson, Y. Ding, M. J. McElrath, J. C. Guatelli, and O. O. Yang Broadly Increased Sensitivity to Cytotoxic T Lymphocytes Resulting from Nef Epitope Escape Mutations J. Immunol., October 15, 2003; 171(8): 3999 - 4005. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. O. Yang, P. T. Nguyen, S. A. Kalams, T. Dorfman, H. G. Gottlinger, S. Stewart, I. S. Y. Chen, S. Threlkeld, and B. D. Walker Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes J. Virol., February 15, 2002; 76(4): 1626 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Wang, E. Kiyokawa, E. Verdin, and D. Trono The Nef protein of HIV-1 associates with rafts and primes T cells for activation PNAS, January 4, 2000; 97(1): 394 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang and D. Gabuzda Regulation of Human Immunodeficiency Virus Type 1 Infectivity by the ERK Mitogen-Activated Protein Kinase Signaling Pathway J. Virol., April 1, 1999; 73(4): 3460 - 3466. [Abstract] [Full Text] |
||||
![]() |
X. Yang and D. Gabuzda Mitogen-activated Protein Kinase Phosphorylates and Regulates the HIV-1 Vif Protein J. Biol. Chem., November 6, 1998; 273(45): 29879 - 29887. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Aldrovandi, L. Gao, G. Bristol, and J. A. Zack Regions of Human Immunodeficiency Virus Type 1 nef Required for Function In Vivo J. Virol., September 1, 1998; 72(9): 7032 - 7039. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Hodge, K. J. Dunn, G. K. Pei, M. K. Chakrabarty, G. Heidecker, J. A. Lautenberger, and K. P. Samuel Binding of c-Raf1 Kinase to a Conserved Acidic Sequence within the Carboxyl-terminal Region of the HIV-1 Nef Protein J. Biol. Chem., June 19, 1998; 273(25): 15727 - 15733. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. X. Liu, F. Margottin, S. Le Gall, O. Schwartz, L. Selig, R. Benarous, and S. Benichou Binding of HIV-1 Nef to a Novel Thioesterase Enzyme Correlates with Nef-mediated CD4 Down-regulation J. Biol. Chem., May 23, 1997; 272(21): 13779 - 13785. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Coates, S. J. Cooke, D. A. Mann, and M. P. G. Harris Protein Kinase C-mediated Phosphorylation of HIV-I Nef in Human Cell Lines J. Biol. Chem., May 9, 1997; 272(19): 12289 - 12294. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Collette, H. Dutartre, A. Benziane, F. Ramos-Morales, R. Benarous, M. Harris, and D. Olive Physical and Functional Interaction of Nef with Lck J. Biol. Chem., March 15, 1996; 271(11): 6333 - 6341. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |